Advanced search
Publication Cover
Future Oncology Volume 20, 2024 - Issue 14
Submit an article Journal homepage
1,214
Views
0
CrossRef citations to date
0
Altmetric
Research Article

INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice

Xavier Leleu1 Púle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, 86000, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9822-4170
ORCID Icon,
Hans C Lee2 M.D. Anderson Cancer Center, Houston, TX77030, USA
,
Jeffrey A Zonder3 Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI48201, USA
,
Margaret Macro4 CHU de Caen, Caen, 14000, France
,
Karthik Ramasamy5 Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, OX3 7LE, UK
,
Cyrille Hulin6 CHU de Bordeaux, Bordeaux, 33000, France
,
Jiri Silar7 Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic
,
Matyas Kuhn7 Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic
,
Kaili Ren8 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA02421, USA
,
Nawal Bent-Ennakhil9 Takeda Pharmaceuticals International AG, Opfikon, 8152, Switzerland
,
Dasha Cherepanov8 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA02421, USA
,
Dawn Marie Stull10 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA02421, USA
&
Evangelos Terpos11 Department of Clinical Therapeutics, National & Kapodistrian University of Athens, School of Medicine, Athens,115 27, Greece
 show all
Pages 935-950 | Received 14 Jul 2023, Accepted 01 Dec 2023, Published online: 10 Jan 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.